
Takeda - Better Health, Brighter Future[Enable Accessibility](#)[Enable Accessibility](#)[![HOME](https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/corporate/takeda_logo)Better Health, Brighter Future](/) [Newsroom](/newsroom/) [Careers](/careers/) [Investors](/investors/) [Patients](/patients/) [HCPs](/hcps/)[Worldwide](/worldwide/)[![](https://assets-dam.takeda.com/image/upload/v1/legacy-dotcom/globalassets/corporate/takeda_logo)](/)Who We Are[**About Takeda**How can we do more for our patients?  
Everything at Takeda starts with this question.Learn more](/who-we-are/)**[Company Information](/who-we-are/company-information/)**[Company Facts & Japan offices](/who-we-are/company-information/company-facts/)[History](/who-we-are/company-information/history/)[Worldwide Offices](/who-we-are/company-information/worldwide-offices/)[Executive Leadership](/who-we-are/company-information/executive-leadership/)[Positions](/who-we-are/company-information/Positions/)**[Takeda Global Headquarters](/who-we-are/Takeda-Global-Headquarters/)**[Design Concept](/who-we-are/Takeda-Global-Headquarters/design-concept/)[Where we work](/who-we-are/Takeda-Global-Headquarters/Where-we-work/)**[Corporate Philosophy](/who-we-are/corporate-philosophy/)****[Corporate Governance](/who-we-are/corporate-governance/)**[Values and Corporate Governance](/who-we-are/corporate-governance/value/)[Board of Directors](/who-we-are/corporate-governance/board-of-directors/)[Nomination Committee and Compensation Committee](/who-we-are/corporate-governance/nomination-and-compensation-committee/)[Audit and Supervisory Committee and Internal Audit](/who-we-are/corporate-governance/audit/)[Our Management](/who-we-are/corporate-governance/corporate-management/)[Charters and Reports, etc.](/who-we-are/corporate-governance/charters-and-reports/)**[Risk & Crisis Management](/who-we-are/risk-crisis-management/)****[Global Ethics & Compliance / Global Code of Conduct](/who-we-are/global-ethics-compliance/)****[Transparency Disclosures](/who-we-are/transparency-disclosures/)**[EFPIA Disclosure Code Reports](/who-we-are/transparency-disclosures/efpia-disclosure-code-reports/)[Patient Group Disclosures](/who-we-are/transparency-disclosures/patient-organization-funding/)**[Contact Us](/who-we-are/contact-us/)**[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/top/howwework_logo_1600x900)## 
Celebrating the grand opening of Takeda Global HeadquartersLEARN MORE](/who-we-are/Takeda-Global-Headquarters/) What We Do[**Our Business**We will become a global, values-based, R&D-driven, biopharmaceutical leaderLearn more](/what-we-do/)**[Research & Development](/what-we-do/research-and-development/)**[Science Stories](/what-we-do/research-and-development/science-stories/)[Our Pipeline](/what-we-do/research-and-development/our-pipeline/)[Clinical Trials](/what-we-do/research-and-development/takeda-clinical-trial-transparency/)[R&D Partnering](/what-we-do/research-and-development/rd-partnering/)[Supporting the Scientific Community](/what-we-do/research-and-development/Supporting-Scientific-Community/)**[Areas of Focus](/what-we-do/areas-of-focus/)**[Oncology](/en/shortcut_content_140926/)[Rare Diseases](/what-we-do/areas-of-focus/rare-diseases/)[Neuroscience](/what-we-do/areas-of-focus/neuroscience/)[Gastroenterology](/what-we-do/areas-of-focus/gastroenterology/)[Plasma-Derived Therapies](/what-we-do/areas-of-focus/plasma-derived-therapies/)[Vaccines](/what-we-do/areas-of-focus/vaccines/)**[Alliances & Partnerships](/what-we-do/alliances-partnerships/)**[Takeda Digital Ventures](/what-we-do/alliances-partnerships/tdv/)**[Our Products](/what-we-do/our-products/)****[Manufacturing](/what-we-do/manufacturing/)**[Innovation Story](/what-we-do/manufacturing/innovation-story/)**[Access to Medicines](/what-we-do/access-to-medicines/)**[Our Approach and Our Position](/what-we-do/access-to-medicines/approach-and-position/)[Hear from Patients](/what-we-do/access-to-medicines/hear-from-patients/)[Driving Impact with Partners](/what-we-do/access-to-medicines/driving-impact/)[Pre- Approval Access](/what-we-do/access-to-medicines/pre-approval-access/)**[Suppliers](/what-we-do/suppliers/)**[Sustainable Procurement](/what-we-do/suppliers/sustainable-procurement/)[Supplier Code of Conduct](/what-we-do/suppliers/supplier-code-of-conduct/)[Supplier Diversity](/what-we-do/suppliers/supplier-diversity/)[Third Party Risk Management](/what-we-do/suppliers/third-party-risk-management/)[Become a Takeda Supplier](/what-we-do/suppliers/becoming-a-takeda-supplier/)[Responsible Procurement](/what-we-do/suppliers/responsible-procurement/)[Purchase Orders and Invoices](/what-we-do/suppliers/purchase-orders-and-invoices/)[Takeda Supplier Solutions Portal](/what-we-do/suppliers/takeda-supplier-solutions-portal/)[Contact us](/what-we-do/suppliers/contact-us/)**[T-CiRA](/what-we-do/t-cira/)**[About T-CiRA](/what-we-do/t-cira/about/)[Leaders Message](/what-we-do/t-cira/leaders/)[What we do](/what-we-do/t-cira/whatwedo/)[Portfolios](/what-we-do/t-cira/portfolios/)[Projects](/what-we-do/t-cira/members/)[Inside T-CiRA](/what-we-do/t-cira/inside/)[Research Achievements](/what-we-do/t-cira/achievements/)[Future of iPSC](/what-we-do/t-cira/future/)[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/en-gb/home/what-we-do/2.2therapeuticareas_block_003)## 
We focus on our core therapeutic areas.LEARN MORE](/what-we-do/areas-of-focus/) Our Stories[**Our Stories**Two centuries. Countless innovations. One vision.Learn more](/our-stories/)**[All Stories](/our-stories/all-stories/)** Corporate Responsibility[**Takeda's CSR**Takeda is committed to addressing the world’s biggest challenges to sustainable development over the long term.LEARN MORE](/corporate-responsibility/)**[Programs in Action](/corporate-responsibility/programs-in-action/)**[Takeda Chair in Global Child Health](/corporate-responsibility/programs-in-action/takeda-chair/)[Takeda Initiative for the Global Fund](/corporate-responsibility/programs-in-action/takeda-initiative/)**[Global CSR Program](/corporate-responsibility/global-csr-program/)**[Apply for Funding](/corporate-responsibility/global-csr-program/apply/)[Frequently Asked Questions](/corporate-responsibility/global-csr-program/faq/)**[Leaders Driving Change](/corporate-responsibility/leaders-driving-change/)****[Purpose led-Sustainability at Takeda](/corporate-responsibility/purpose-led-sustainability-at-takeda/)****[Patient](/corporate-responsibility/patient/)****[People](/corporate-responsibility/people/)****[Planet](/corporate-responsibility/planet/)****[Governance](/corporate-responsibility/governance/)****[Reporting on Sustainability](/corporate-responsibility/reporting-on-sustainability2/)**[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/jp/home/corporate-responsibility/takeda-life-theater/01_herobanner)## 
TAKEDA LIFE THEATER, Embark on a journey of discovery inside the human body!LEARN MORE](/corporate-responsibility/life-theater/)  [![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/w_1000,ar_16:9,c_fill,g_auto,e_sharpen/q_auto:eco/f_auto/v1/siteassets/system/what-we-do/areas-of-focus/rare-diseases/rare-disease-day/GettyImages-1138269305)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/w_1000,ar_16:9,c_fill,g_auto,e_sharpen/q_auto:eco/f_auto/v1/siteassets/system/what-we-do/areas-of-focus/rare-diseases/rare-disease-day/GettyImages-1138269305)](/what-we-do/areas-of-focus/rare-diseases/rare-disease-day-2023)Takeda's focus on health equity; Rare Disease Day 2023
[LEARN MORE](/what-we-do/areas-of-focus/rare-diseases/rare-disease-day-2023)#### Welcome to the GlobalCorporate Website for Takeda
If you are looking for specific information,
please visit our country/region website. 
[SELECT A COUNTRY OR REGION SITE](/worldwide/)[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/siteassets/system/investors/financial_1600x900)## 
Earnings announcement for the 3rd quarter FY2022 (Feb 2, 2023)LEARN MORE](/investors/financial-results/)[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/our-stories/a-passion-for-sustainability-is-driving-industry-leading-co2-savings-in-austria/vienna_first-industry-green-building-in-gold-in-austria)## 
A passion for sustainability is driving industry-leading CO2 savings in AustriaLEARN MORE](/our-stories/all-stories/stories/a-passion-for-sustainability-is-driving-industry-leading-co2-savings-in-austria/)RECENT NEWSSTOCK PRICEMarch 13th, 202303/13/2023[Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine \[Live, Attenuated]) Approved in Brazil for Use Regardless of Prior Dengue Exposure](/newsroom/newsreleases/2023/takedas-qdenga-approved-in-brazil) [GO TO NEWSROOM](https://www.takeda.com/newsroom/)Please wait...
## Topics
[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/investors/annual-integrated-report_icon)## 
2022 Annual Integrated ReportLEARN MORE](/corporate-responsibility/reporting-on-sustainability/annual-integrated-report/)[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/siteassets/system/newsroom/featured-topics/luck-is-not-a-strategy-the-world-needs-to-start-preparing-now-for-the-next-pandemic/andy_plump)## 
Andy Plump discusses maintaining trust in science.LEARN MORE](/newsroom/featured-topics/maintaining-trust-in-science-is-crucial-to-public-health-heres-how-the-biopharma-industry-can-help/)[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/newsroom/featured-topics/building-on-research-to-bring-innovation-to-patients/t-cira-preview-image---mobile)## 
Our StoriesLEARN MORE](/our-stories/)[![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)![](https://assets-dam.takeda.com/image/upload/c_lfill,w_3840/q_auto:eco/f_auto/v1/legacy-dotcom/globalassets/system/corporate-responsibility/csr_ogp)## 
Corporate ResponsibilityLEARN MORE](/corporate-responsibility/)## Information
|  |
| --- |
| [Earnings announcement for the 3rd quarter FY2022 (February 2, 2023)](https://www.takeda.com/investors/financial-results/) |
| [41st Annual J.P. Morgan Healthcare Conference (4:30pm – 5:10pm PST on January 9, 2023)](https://www.takeda.com/investors/ir-events/) |
| [146th Ordinary General Meeting of Shareholders (June 29, 2022)](https://www.takeda.com/investors/shareholders-meetings/) |
| [Information for US Patients Regarding the NATPARA Recall in the US](https://www.natpara.com/recall#/latest-updates) |
| [ADS Helpline](https://www.takeda.com/investors/stock-and-shares/procedure/) |
 
CloseTOP[Terms of Use](/terms-of-use/)[Takeda Privacy Notice](/privacy-notice/)[Cookie Policy](/cookie-policy/)[Accessibility Statement](/accessibility-statement/?lang=en)Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.Connect with us:    [Worldwide](/worldwide/)Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.Close
